Tesamorelin is a synthetic peptide analog of growth hormone–releasing hormone (GHRH) that is studied for its ability to stimulate the pituitary gland to increase endogenous growth hormone production. Researchers examine its effects on metabolic processes, particularly its role in regulating lipid metabolism and reducing visceral adipose tissue. It is also investigated for its influence on insulin-like growth factor 1 (IGF-1) levels and its potential impact on body composition and metabolic health in controlled laboratory settings.
This compound is intended strictly for laboratory research purposes only and is not for human consumption or veterinary use.